San Diego, United States
Juno Diagnostics, established in 2017 and headquartered in the United States, is a biotechnology company focused on revolutionizing prenatal testing with their slogan, "Prenatal Testing Reimagined". Their mission targets supporting growing families through innovative and accessible prenatal screening assays based on cell-free DNA technology.
Despite the promising vision, it is important to note that Juno Diagnostics has permanently closed its commercial operations. This decision significantly impacts their potential for future revenue generation and market presence.
The company's last financial activity was a Series A investment on May 25, 2021, led by Bioverge Ventures. While the technology and market prospect in prenatal diagnostics continue to grow, the closure of commercial operations presents a major risk factor to consider for future investments.
